We examined 10 monoclonal antibodies (mAbs) directed against Mycoplama pneumoniae proteins of 200, 170,67,46 and 42 kDa, and one mAb directed against a glycolipid component. The membrane association of the antigens reacting with our mAbs was investigated, in particular by phase-fractionation involving use of the detergent Triton X-114. The 170 kDa protein was shown to be membrane-associated, and surface exposure of this antigen was demonstrated by its disappearance from SDS-PAGE patterns after treatment of intact mycoplasmas with proteolytic enzymes. Cross-reactions with protein antigens of Mycoplasma genitalium were also shown. A mAb directed against a component of a lipid extract, prepared by the method used for preparation of the antigen used in the complement fixation (CF) test for serological diagnosis of M . pneumoniae infection, reacted with one major and a few minor bands in thin-layer chromatography (TLC) of the crude extract. The glycolipid character of this major antigen was demonstrated by treatment of the extract with sodium periodate, and by development of the TLC with orcinol/ferric chloride. These reactive bands were the same as those detected by the use of polyclonal mouse antiserum and a human convalescent serum, a result showing that the CF antigen contains a glycolipid moiety reacting with our mAb. The surface exposure of this antigen was demonstrated by binding of mAbs to intact cells.
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We examined 10 monoclonal antibodies (mAbs) directed against Mycoplama pneumoniae proteins of 200, 170, 67, 46 and 42 kDa, and one mAb directed against a glycolipid component. The membrane association of the antigens reacting with our mAbs was investigated, in particular by phase-fractionation involving use of the detergent Triton X-114. The 170 kDa protein was shown to be membrane-associated, and surface exposure of this antigen was demonstrated by its disappearance from SDS-PAGE patterns after treatment of intact mycoplasmas with proteolytic enzymes. Cross-reactions with protein antigens of Mycoplasma genitalium were also shown. A mAb directed against a component of a lipid extract, prepared by the method used for preparation of the antigen used in the complement fixation (CF) test for serological diagnosis of M . pneumoniae infection, reacted with one major and a few minor bands in thin-layer chromatography (TLC) of the crude extract. The glycolipid character of this major antigen was demonstrated by treatment of the extract with sodium periodate, and by development of the TLC with orcinol/ferric chloride. These reactive bands were the same as those detected by the use of polyclonal mouse antiserum and a human convalescent serum, a result showing that the CF antigen contains a glycolipid moiety reacting with our mAb. The surface exposure of this antigen was demonstrated by binding of mAbs to intact cells.
I N T R O D U C T I O N
Several antigens of Mycoplasma pneumoniae have been investigated with respect to their immunogenicity and their role in pathogenesis. One major immunogen of this organism is a surface-exposed protein of 165-170 kDa, designated PI and known to mediate the adhesion of M . pneumoniae to respiratory epithelial cells (Hu et al., 1977 (Hu et al., , 1982 . This and several other protein antigens have been shown to elicit serum antibodies in naturally infected humans, experimentally infected hamsters and immunized rabbits (Jacobs et al., 1986; Leith et al., 1983) . Vu et al. (1 987) assigned protein antigens of M . pneumoniae molecular masses of 170, 130, 90, 45 and 35 kDa on the basis of their migration in SDS-PAGE. In other studies, protein antigens of 168, 110 and 32 kDa have been shown to be surface-exposed by whole-cell radioimmunoprecipitation assay (Leith et al., 1983; Morrison-Plummer et al., 1986) . The attachment of mycoplasmas to chicken erythrocytes was inhibited by monoclonal antibodies (mAbs) to these protein antigens. Membrane association of a 43 kDa protein was suggested by use of phase fractionation of M . pneumoniae components in the detergent Triton X-114 (Cimolai et al., 1987) . mAbs against a 43 kDa protein reacted with all clinical isolates of M . pneumoniae as determined by immunoblot analysis, but not with normal-flora Mycoplasma spp. or 18 other microorganisms potentially inhabiting the normal or diseased respiratory tract (Madsen et al., 1986) .
In another study, a mAb to a 43 kDa protein of M . pneumoniae also cross-reacted in immunoblots with Mycoplasrna genitulium and Acholeplusma laidlawii proteins of similar molecular masses (Cimolai et al., 1987) . The P 1 protein (1 70 kDa) of M . pneumoniae was shown to share epitopes with a 140 kDa protein of M . genitaliurn (Morrison-Plummer et al., 1987) .
The predominant antigen used in the complement fixation (CF) test for serological diagnosis of pneumonia caused by M . pneumoniue is a glycolipid (Plackett et al., 1969) .
The purpose of this study was to identify antigens of M . pneumoniae that could be detected in clinical samples by mAbs. The factors that might influence the suitability of the antigens for such an assay include their surface location and membrane association. In this paper we characterize six antigens of M . pneumoniae, including a glycolipid antigen, with regard to their chemical nature, surface exposure, membrane association and cross-reactivities with other mycoplasmas.
METHODS
Bacterial strains and culture conditions. Mycoplasma pneumoniue strain FH (ATCC 15531) was grown in Roux bottles in a medium containing (per litre) 14 g PPLO broth (Difco), 25 g yeast extract (Difco), 20 mmol HEPES buffer (Merck), 4 g glucose, 5 mmol KOH, 200 ml horse serum, 4 x lo5 IU penicillin and 200 mg thallium acetate.
Mycoplasma genitafium (G-37, kindly provided by K . Lind, Statens Seruminstitut, DK-2300 Copenhagen, Denmark) was also grown in this medium, with the omission of thallium acetate. After 48-72 h at 37 "C, the medium was removed, and the mycoplasmas adhering to the glass surface were washed four times with phosphatebuffered saline (0.15 M-NaCl, 0.15 M-sodium phosphate, pH 7.3; PBS) and harvested in PBS by rolling glass beads gently over the surface. The mycoplasmas were then collected by centrifugation of the suspension for 30 min at Mycoplasma hominis (PG 21), Mycoplasmu orale (isolated from an infected cell culture), Mycoplasma frrmuntans (PG 18) and Acholeplusma laidlawii (PG 9), as whole-cell preparations in PBS, stored at -80 "C, were kindly provided by Goran Bolske, National Veterinary Institute, S-75007 Uppsala, Sweden. The protein content of all the preparations was determined by the Lowry method.
Preparation of' antisrra. Antigen for immunization was prepared by growing M . pneumoniae in the medium described above, except that horse serum was replaced by rabbit serum. Mouse polyclonal antiserum to M . pneumoniae was prepared by inoculating Balb/c mice intraperitoneally with the mycoplasma antigen (100 pg protein) suspended in Freund's complete adjuvant (FCA; Difco). Two weeks later and twice thereafter at 2 week intervals the mice were similarly inoculated with the antigen (1 00 pg), suspended in Freund's incomplete adjuvant (FIA; Difco). After another 2 weeks, the mice were boosted with antigen (100 pg), suspended in 0.9% NaCl, and cord blood was collected 12 d later.
Human convalescent serum was obtained from a patient with a mycoplasmal pneumonia, included in a prospective study of pneumonia patients (Hirschberg et al., 1988) . This serum had a C F titre of 640.
Development ofmAfbs. Female Balb/c mice were immunized by injecting mycoplasmal antigen (50 pg protein) in FCA both intraperitoneally and in the footpad. The mice were boosted twice intraperitoneally, the first time after 3 weeks with antigen (50 pg) in FIA, and the second time after another 3 weeks with the same amount in PBS. The mice were bled 1 d prior to spleen-cell fusion and the mouse with the highest antibody titre to M . pneumoniae was selected as spleen donor.
The spleen cells were fused with SP2/0 non-secreting plasmacytoma cells following the method used by Fazekas de St Groth & Scheidegger (1980) , except that the cells were fused at a ratio of five spleen cells to two SP2/0 cells and seeded into 96-well microtitre plates at a cell density of 1.3 x lo5 SP2/0 per well. Medium supernatant (100 pl volumes) was collected and tested in an enzyme immunoassay (EIA) for specific antibodies to M . pnrumoniur. The wells in Dynatech micro-ELISA plates M 129A were coated with mycoplasma protein [lo0 pl (1 pg), in 10 mMcarbonate buffer pH 9.61 and incubated overnight at 37 "C. After washing three times in PBS with O.OS:/d Tween 20 (PBS-Tween), the wells were incubated with 5% (w/v) bovine serum albumin (BSA; Boehringer Mannheim) 150 p1, in PBS-Tween for 15 min at room temperature. Hybridoma supernatants were added to the wells after washing and the plates were incubated for 1 h at 37 "C. Murine antibody activity was demonstrated after another washing by incubating the wells for 1 h at 37 "C with 100 p1, appropriately diluted, sheep anti-mouse-Ig-alkaline phosphatase conjugate (NEN Products). The supernatants were tested in parallel on horse-serum-coated wells to avoid selection of cells secreting antibodies against horse serum components. Finally, 100 pl of substrate ( pnitrophenyl phosphate, 1 mg ml-' in 50 mM-carbonate buffer pH 9.6) was added after another washing cycle and the plates were incubated at 37 "C for 1 h. The absorbance at 405 nm was then read. Positive cell cultures were selected and subsequently cloned by limiting dilution one to four times to obtain monoclonal cell lines.
EIA titres on culture supernatants harvested from recloned cell lines were determined as described above, with the following modifications. The plates were incubated with hybridoma supernatant diluted in 0.5% BSA in PBSTween, and incubated for 1 h at 37 "C. After three washes, each well was inoculated with rabbit anti-mouse-Ighorseradish peroxidase (HRP) conjugate (Dakopatts), diluted l/500 in 0.5% BSA in PBS-Tween and incubated for I h at 37 "C, then washed another three times before addition of the substrate, 100 pl 0.1 mg ml-' 3,3',5,5'-tetramethylbenzidine (Merck) in 0.1 M-acetate buffer, pH 6-0, and 0.002% (v/v) HzOz. The reaction was stopped after 5 rnin by addition of 50 p1 2 M-H~SO, and the absorbance at 450 nm was read. The titres of supernatants containing mAb activity are reported as the reciprocal of the dilution giving approximately 0.1 absorbance unit.
To check for monoclonality and stability of the hybridoma cell lines, selected culture supernatants were analysed by isoelectric focussing (IEF) in agarose gels with an ULTHROPHOR 2217 electrofocusing unit, together with a power supply, model 2197 (LKB). The gels were fixed and stained using an in situ EIA method, whereby the gels were incubated for 30 min at room temperature with immunoabsorbed rabbit anti-mouse Ig antisera according to Ritchie & Smith (1976) , followed by incubation for 30 rnin at room temperature with a protein A-HRP conjugate prepared according to Boorsma & Streefkerk (1 979). The gels were then incubated in darkness at room temperature for 20 rnin in substrate [ 1 m~-3-aminoethylcarbazole (Sigma) in 0.2 M-acetate buffer, pH 5.0, with 0.0075'4 HZ02]. The reaction was stopped by extensive washing of the gel in distilled water. The gels were air-dried and evaluated.
Isotyping of mAbs was done with EIA using microtitre plates coated with purified IgG fractions of rabbit antimouse subclass-specific antisera (Zymed Laboratories), diluted I/ 1000. Cell culture supernatants were added to the wells and incubated for 1 h at 37 "C. After washing, the wells were incubated for 1 h at 37 "C with sheep antimouse Ig-alkaline phosphatase conjugate (NEN Products), 100 p1 per well at an appropriate dilution. Finally, 100 p1 substrate buffer containing p-nitrophenyl phosphate (1 mg ml-' in 50 mM-carbonate buffer, pH 9.6) was added. The plates were incubated at 37 "C for 1 h and the absorbance read at 405 nm.
Cloned cell lines selected by the above procedures were injected intraperitoneally into mice to produce ascitic fluid containing mAbs (Brodeur & Tsang, 1986) for use in tests requiring a higher concentration of mAbs for evaluation.
Immunoblutting. SDS-PAGE was performed according to Laemmli (1970) . Mycoplasma protein (540 pg) was distributed along the anodic side of the gel and separated in a 12% (w/v) polyacrylamide gel for 6 h and 1 +4 mA cm-' . The gel was applied to a nitrocellulose sheet and the blotting was run at 17 mA cm-2 overnight (Towbin et a/., 1979) . The sheet was then placed for 1 h in 20 mM-Tris/HCl, 500 mM-NaC1, 0.05% Tween 20 pH 7-5 (TTBS), at room temperature. The nitrocellulose sheet was cut into strips which were placed in a polyvinylchloride tray with troughs, to which samples of hybridoma supernatants were added, and the tray then gently rocked overnight at 4 "C. One quick rinse with distilled water and three washes for 10 rnin with TTBS followed, before addition of HRP-conjugated rabbit immunoglobulins to mouse Ig (Dakopatts), diluted 100 times in TTBS. The nitrocellulose strips were incubated at 4 "C for 1 h with gentle rocking, washed as before, and a substrate solution, prepared as follows, was added: 60 mg 4-chloro-1-naphthol (Sigma) was dissolved in 20 ml cold methanol and 100 m120 mM-Tris/HCl, 500 mM-NaC1, pH 7.5, was added; immediately before use, 60 ~1 3 0 % (v/v) HzOz was added. The reaction was stopped after 10 rnin incubation at room temperature by extensive washing with distilled water.
Glycolipid antigen and its use in EIA. Extraction of glycolipid was performed as described by Morrison-Plummer e? a/. (1983) . This preparation of mycoplasma lipid was diluted l/l000 in methanol and used as antigen for coating microtitre plates (Dynatech M 129A) in 100 pl amounts. The solvent was evaporated at 37 "C and the plates were stored dry at 4°C for several months. The EIA was performed as described above for antibody titration in hybridoma supernatants.
Treatment q f M . pneumoniae in microtitre plates with periodate andpronase. The wells were coated with 100 p1 M .
pneumoniae protein (1 0 pg ml-I ) as described above. Before adding 5 % BSA in PBS-Tween, the wells were treated with periodate (Woodward el a/., 1985) or pronase as follows. The wells were incubated with 100 p180 mM-NaIO, (Sigma) for 30 rnin at 37 "C, and washed three times with PBS-Tween. After treatment for 1 h with 100 p10-16 Methyleneglycol in PBS at 37 "C, the wells were washed once with PBS-Tween and incubated with 200 p120 mMpoly-L-lysine (Sigma) for 1 h at 20 "C, followed by one wash with PBS-Tween. The wells to be treated with pronase were incubated overnight at room temperature with 100 pl pronase (Boehringer Mannheim; 0.01 mg ml-l in PBS) and washed three times with PBS-Tween. Treated wells were incubated with 5% BSA in PBS-Tween for 15 rnin at room temperature. The EIA was then performed as described above for antibody titration in hybridoma supernatants.
EIA on intact M . pneumoniae organisms. M . pneumoniae was grown as monolayers in 100 p1 volumes in Sterilin microtest plates (M 29ARTL) at 37 "C. After 24 h, 100 p1 formaldehyde (0.1 % in PBS) was added to each well and the plates were incubated at room temperature for 15 rnin before being washed five times with PBS-Tween. The EIA was performed as described above for antibody titration in hybridoma supernatants, except that ascitic fluid was used.
L . H I R S C H B E R G , T . H O L M E A N D N . H Y D E N
Treatment of intact organisms with trypsin and protease K . Mycoplasmas were grown as monolayers in Roux bottles for 24 h, washed three times with PBS and incubated with 0-05 % (w/v) trypsin or protease K (Sigma) for 30 min (trypsin) or 3 h (protease K) at 37 "C. The reaction was stopped by addition of phenylmethylsulphonyl fluoride to a final concentration of 1 mM, followed by incubation for 15 min at 37 "C. The mycoplasmas were collected as described above, and samples were analysed by SDS-PAGE. Zmmumjfuorescence. M . pneumoniae was grown for 24 h in wells on immunofluorescent printed glass slides (Erie Scientific). After fixation for 10 min with 0.1 % formaldehyde in PBS, the wells were washed five times with PBS and incubated for 30 min at room temperature with hybridoma supernatant or ascitic fluid in appropriate dilutions. The wells were again washed five times with PBS and incubated for 30 rnin at room temperature with fluorescein-conjugated rabbit anti-mouse immunoglobulins (Dakopatts) diluted 1 /2 in PBS. Glycerol, diluted 1/2 in PBS, was added to the wells after washing five times with PBS, and glass coverslips were carefully mounted on the slides. The microscopic evaluation was done with a Zeiss fluorescence microscope ( x 1000). Phase fractionation of M . pneumoniae proteins. Triton-XI 14 (Sigma) was used to separate mycoplasma components into hydrophobic and hydrophilic fractions, using the method of Bordier (198 l), modified by Riethman et a f . (1987) . Briefly, mycoplasma protein (2 mg ml-' in PBS) was solubilized by addition of prewashed Triton X-114 to a final concentration of 1 % (v/v) and incubated for 30 rnin at 4 "C. After centrifugation for 10 rnin at 4 "C and 13000g, the supernatant was removed and incubated for 5 rnin at 37 "C. The suspension was centrifuged at 22 "C for 5 rnin at 13000g and the aqueous (upper) phase transferred to a new tube: Trition X-114 was added to the aqueous and the detergent phases to final concentrations of 1%. The fractionation steps described above were repeated three times. From an initial volume of 10 ml in PBS (protein content 20 mg), the final volumes of the detergent phase and aqueous phase were 0.5 and 9.5 ml respectively. To eliminate the detergent and to concentrate the fractions, samples were precipitated using the method of Wessel & Flugge (1984) . Briefly, 0.4 ml methanol was added to 0.1 ml sample and then vortexed and centrifuged for 10 s at 9000g before addition of 0.1 ml chloroform. The samples were vortexed and centrifuged again, then 0-3 ml water was added and the samples were vortexed vigorously and centrifuged for 1 rnin at 900 g. After removal of the upper phase, 0.3 ml methanol was added to the lower phase, and the samples were then vortexed and centrifuged for 5 rnin at 9000 g. The supernatants were removed and the pellets were dried. The precipitation procedure was repeated twice and the samples finally suspended in 25 pl sample buffer for SDS-PAGE and immunoblotting. Control samples of unfractioned mycoplasmas were also prepared in this way before loading on the gel.
Thin-layer chromatography (TLC).
The lipids of M . pneumoniae were extracted using the procedures described by Morrison-Plummer et a f . (1983) or Kenny & Grayston (1965) (see Results). The extracted lipids (equivalent to CF antigen preparations used for mycoplasma serology) were separated on Whatman K6 TLC plates by use of chloroform/methanol/water (65 : 25 : 4, by vol.). The plates were developed with the immunological methods described by Mattsby-Baltzer & Alving (1 984), with some modifications. After chromatography the plates were incubated for 1 h at room temperature in TTBS, followed by overnight incubation after addition of ascitic fluid containing mAb diluted 1/50, or mouse or human antisera diluted 1/200 in TTBS. The plates were washed three times for 10 rnin with TTBS and incubated for 1 h at 37 "C with the HRP-conjugated second antibodies: rabbit anti-mouse or goat anti-human immunoglobulins diluted 1 /ZOO in TTBS. Colour-developing reagent, 4-chloro-1 -naphthol as described above, was added after another three washings and the reaction was stopped after 5 min by extensive washing in HzO.
Control plates were developed after chromatography with orcinol/ferric chloride for detection of glycolipids (Svennerholm, 1956) or with molybdophosphoric acid for phospholipids (Jacin & Mishkin, 1965) .
R E S U L T S
Characteristics of the mAbs mAbs were produced in order to locate different antigens in M . pneurnoniae organisms. Eleven stable hybridomas were established. Some characteristics of the mAbs are presented in Table 1 . The monoclonality of the resulting cell lines was checked by analysis of the band patterns obtained in IEF and by immunoglobulin isotyping.
Ten of the mAbs reacted with protein antigens. By use of SDS-PAGE and immunoblotting of M . pneumoniae proteins, five different protein antigens were revealed, and their molecular masses estimated at 200, 170, 67,47 and 42 kDa (Table 1) . By immunoblotting with polyclonal mouse antiserum, three additional antigens could be demonstrated, with molecular masses of 110, 60 and 32 kDa (results not shown). Pronase-treated whole-cell antigen in an EIA-plate did not react with any of these mAbs, whereas treatment with periodate had no effect on reactivity. The one mAb (25 : 8) that was unreactive with protein antigens did react in the lipid-EIA, whereas the other 10 mAbs were negative. In whole-cell EIA plates treated with pronase, the reaction of mAb 25 : 8 was unaffected, whereas periodate-treated plates showed no immunological reaction. These results indicate that the determinant recognized by this mAb was of carbohydrate nature. Attempts to clarify whether mAbs directed to the same protein antigen reacted with the same epitope were successful only with the mAbs to the 42 kDa protein (results not shown). With the use of mAbs conjugated to HRP in an EIA in which their binding to the antigen was inhibited by incubation with unlabelled mAb, we observed that the two mAbs to the 42 kDa protein reacted with the same epitope. 
Cross-reactions with other mycoplasmas
Exposure of antigens on the bacterial surface
To find out whether the antigens recognized by the mAbs were exposed on the surface of intact mycoplasmas, cells growing on glass or plastic surfaces were treated with trypsin or protease K. Only the 170 kDa protein was degraded by the enzymes, as demonstrated by the subsequent analysis of the protein profile in SDS-PAGE and immunoblotting with mAbs.
A strong positive immunofluorescence reaction was seen with M . pneumoniae grown on glass slides and incubated with the mAb directed against the glycolipid antigen. An equally strong reaction was obtained with mouse polyclonal antiserum. The reactions obtained after incubation with the other mAbs were very weak. In the EIA using mycoplasmas grown directly on the plate, binding of the mAb directed against the glycolipid antigen was clearly demonstrated. The reactions of mAbs against the protein antigens, including those directed against the 170 kDa protein, were very weak. This indicates that these antigens may not be exposed on the mycoplasma membrane surface or may be present only in very small amounts. Membrane association of protein antigens To demonstrate possible membrane association of M . pneumoniae antigens we used phase fractionation of solubilized mycoplasmas in Trition X-114. The protein antigens of the two phases were analysed by SDS-PAGE (Fig. 1) and immunoblotting. The 170 kDa protein was enriched in the detergent phase, as shown by SDS-PAGE and immunoblotting with mAbs specific for this protein. The 67,47 and 42 kDa proteins were all detected in the aqueous phase, demonstrating their hydrophilic character. The 200 kDa protein could not be detected in either phase, although it could be detected in the unfractionated control. Other proteins not included in the group detected by our mAbs were enriched in the detergent phase, as shown by the presence of discrete bands demonstrated by the staining procedure (105, 70, 37, 32, 30 and 19 kDa ; Fig 1) . The majority of the mycoplasma proteins, however, remained in the aqueous phase.
Reaction of mAb 25 : 8 with the CF antigen With the purpose of demonstrating the specificity of the mAb directed against a carbohydrate determinant, we compared the reactivity of this mAb and mouse antisera to fractionated CF antigen of M . pneumoniae (Fig. 2) , using TLC combined with immunological detection techniques. CF antigen preparations made by the methods described by Kenny & Grayston (1965) and Morrison-Plummer et al. (1983) were compared by TLC and by their reactivities with mouse and human antisera and mAb 25 : 8. The two preparations showed identical band patterns by immunodetection with these sera and by staining with orcinol/ ferric chloride. The band pattern in Fig. 2 was obtained using C F antigen prepared as described by Kenny & Grayston (1965) . One band on the chromatograms reacted strongly with both mouse antiserum and human convalescent serum for M . pneumoniae as well as with mAb 25 : 8. Use of orcinol/ferric chloride as detecting reagent showed that this lipid fraction contained a carbohydrate moiety. The strongest reaction obtained with orcinol/ferric chloride was with a band showing the highest mobility in the solvent mixture chosen (Fig. 2) . This band, however, showed no reaction with any of the mouse or human sera used, or with mAb 25 : 8. Several bands on the chromatograms bound both the mouse and the human sera, as well as mAb 25 : 8.
DISCUSSION
By the use of mAbs we have demonstrated membrane association and surface exposure of M . pneumoniae antigens. We have also analysed cross-reactions with other Mycoplasma spp. We have demonstrated the glycolipid nature of the antigen reacting with one of our mAbs and that it is a component of the CF antigen used in diagnostic serology of mycoplasmas. The mAbs used in this study specify five different protein antigens and one glycolipid. The possible role of most of the antigens described is not known, except for the PI protein (170 kDa), which is a wellcharacterized adhesin mediating the adhesion of M . pneumoniae to the tracheal epithelium. The 110 and 32 kDa proteins demonstrated with mouse polyclonal antiserum may also contribute to the adhesion properties of M. pneumoniae cells, as shown elsewhere for similar antigens (Morrison-Plummer et al., 1986) .
Surface exposure of the 170 kDa protein antigen of M. pneumoniae was demonstrated by its disappearance from SDS-PAGE patterns after treatment of intact mycoplasmas with proteolytic enzymes, a result confirming earlier findings (Hu et al., 1977) . Our failure to demonstrate the surface exposure of protein antigens by immunofluorescence and by EIA on intact organisms with our mAbs may be explained in several ways, e.g. low antigen concentration, lack of exposure resulting from dominance of glycolipid antigen, or unavailability of mAb-reacting epitopes on intact organisms because of the orientation of the proteins. In contrast, a strong positive reaction was obtained with the mAb specific for the glycolipid antigen.
In our phase-fractionation experiments using the detergent Triton X-114, the 170 kDa protein was the only M . pneumoniae antigen of those detectable by our mAbs that could be demonstrated to be membrane associated. With the use of the same techniques a 43 kDa protein has also been proposed to be membrane-associated (Cimolai eta,.; . The 42 kDa protein detected by our mAbs was enriched in the aqueous phase (Fig. l) , a result indicating the predominantly hydrophilic character of this protein. The findings of Morrison-Plummer et al. (1986) , using whole-cell radioimmunoprecipitation assay, that 32, 110 and 165 kDa protein antigens are exposed on the cell surface, are supported by the results of our phase-fractionation experiments, demonstrating the partitioning of proteins of similar molecular masses into the detergent phase. The fact that the 200 kDa protein was not detected in either aqueous or detergent phase indicates that a more potent detergent is needed to solubilize this protein.
The mAb 25 : 8 was the only mAb that reacted with the lipid extract. Further analysis of specific mAb-reacting antigens in this extract by TLC and by staining of the chromatograms with orcinol/ferric chloride demonstrated the presence of carbohydrate components, thus indicating the glycolipid nature of some of the components (Fig. 2) . The fact that mouse antiserum and human convalescent serum against M . pneumoniae bound to the same glycolipids as did mAb 25 : 8 (Fig. 2) suggests that the determinant recognized by the mAb may be one of the antigens in the lipid extract used in the CF test. The fact that the antigen recognized was found in one major and a few minor spots may be explained by small variations in the composition of the lipid part of the molecule.
The cross-reactivity of our mAbs with other mycoplasmas tested in EIA was limited to M . genitalium. It is interesting that all but one of the protein antigens detected by our mAbs shared
